UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 29

Sortiert nach

Early decline in the catecholamine release-inhibitory peptide catestatin in humans at genetic risk of hypertension

Journal of hypertension, 2002-07, Vol.20 (7), p.1335-1345

2002

Link zum Volltext

Verfügbarkeit prüfen

Plasma Hydrogen Peroxide Production in Human Essential Hypertension: Role of Heredity, Gender, and Ethnicity

Hypertension (Dallas, Tex. 1979), 2000-11, Vol.36 (5), p.878-884

2000

Link zum Volltext

Verfügbarkeit prüfen

Development and Validation of a Noninvasive Method to Determine Arterial Pressure and Vascular Compliance

The American journal of cardiology, 1997-08, Vol.80 (3), p.323-330

1997

Link zum Volltext

Verfügbarkeit prüfen

β2-Adrenergic receptor polymorphisms at codon 16, cardiovascular phenotypes and essential hypertension in whites and African Americans

American journal of hypertension, 2000-09, Vol.13 (9), p.1021-1026

2000

Link zum Volltext

Verfügbarkeit prüfen

Diminished renal kallikrein responses to mineralocorticoid stimulation in African Americans: determinants of an intermediate phenotype for hypertension

American journal of hypertension, 2003-04, Vol.16 (4), p.281-289

2003

Link zum Volltext

Verfügbarkeit prüfen

Circulating amylin in human essential hypertension: heritability and early increase in individuals at genetic risk

Journal of hypertension, 2000-11, Vol.18 (11), p.1611-1620

2000

Link zum Volltext

Verfügbarkeit prüfen

Chromogranin A in Human Hypertension: Influence of Heredity

Hypertension (Dallas, Tex. 1979), 1995-07, Vol.26 (1), p.213-220

1995

Link zum Volltext

Verfügbarkeit prüfen

Early Alteration in Glomerular Reserve in Humans at Genetic Risk of Essential Hypertension: Mechanisms and Consequences

Hypertension (Dallas, Tex. 1979), 2001-03, Vol.37 (3), p.898-906

2001

Link zum Volltext

Verfügbarkeit prüfen

The catecholamine release-inhibitory "catestatin" region of chromogranin a: early decline in humans at genetic risk of hypertension

Annals of the New York Academy of Sciences, 2002-10, Vol.971 (1), p.533-535

2002

Link zum Volltext

Verfügbarkeit prüfen

Divergent Effects of Dihydropyridine and Phenylalkylamine Calcium Channel Antagonist Classes on Autonomic Function in Human Hypertension

Hypertension (Dallas, Tex. 1979), 1995-07, Vol.26 (1), p.143-149

1995

Link zum Volltext

Verfügbarkeit prüfen

Arterial Compliance by Cuff Sphygmomanometer: Application to Hypertension and Early Changes in Subjects at Genetic Risk

Hypertension (Dallas, Tex. 1979), 1996-10, Vol.28 (4), p.599-603

1996

Link zum Volltext

Verfügbarkeit prüfen

Human sympathetic activation by α2‐adrenergic blockade with yohimbine: Bimodal, epistatic influence of cytochrome P450–mediated drug metabolism

Clinical pharmacology and therapeutics, 2004-08, Vol.76 (2), p.139-153

2004

Link zum Volltext

Verfügbarkeit prüfen

Expression of altered α2-adrenergic phenotypic traits in normotensive humans at genetic risk of hereditary (essential) hypertension

Journal of hypertension, 1998-06, Vol.16 (6), p.779-792

1998

Link zum Volltext

Verfügbarkeit prüfen

Does lipophilicity of angiotensin converting enzyme inhibitors selectively influence autonomic neural function in human hypertension?

Journal of hypertension, 1994-11, Vol.12 (11), p.1243-1248

1994

Link zum Volltext

Verfügbarkeit prüfen

Variability in phenylephrine response and essential hypertension: a search for human alpha(1B)-adrenergic receptor polymorphisms

The Journal of pharmacology and experimental therapeutics, 1999-11, Vol.291 (2), p.793

1999

Link zum Volltext

Verfügbarkeit prüfen

The Catecholamine Release-Inhibitory "Catestatin" Region of Chromogranin A

Annals of the New York Academy of Sciences, 2002-10, Vol.971 (1), p.533-535

2002

Link zum Volltext

Verfügbarkeit prüfen

Human sympathetic activation by alpha2-adrenergic blockade with yohimbine: Bimodal, epistatic influence of cytochrome P450-mediated drug metabolism

Clinical pharmacology and therapeutics, 2004-08, Vol.76 (2), p.139-153

2004

Link zum Volltext

Verfügbarkeit prüfen

Early alteration in glomerular reserve in humans at genetic risk of essential hypertension: Mechanisms and conquences

Hypertension (Dallas, Tex. 1979), 2001-03, Vol.37 (3), p.898

2001

Link zum Volltext

Verfügbarkeit prüfen

Racial differences in renal kallikrein excretion: Effect of the ovulatory cycle

Kidney international, 1998-11, Vol.54 (5), p.1652-1658

1998

Link zum Volltext

Verfügbarkeit prüfen

β 2-adrenergic receptor polymorphisms at codon 16, cardiovascular phenotypes and essential hypertension in whites and African Americans

American journal of hypertension, 2000, Vol.13 (9), p.1021-1026

2000

Link zum Volltext

Verfügbarkeit prüfen

2-Adrenergic receptor polymorphisms at codon 16, cardiovascular phenotypes and essential hypertension in whites and African Americans

American journal of hypertension, 2000-09, Vol.13 (9), p.1021-1026

2000

Link zum Volltext

Verfügbarkeit prüfen

Hereditary intermediate phenotypes in African American hypertension

Ethnicity & health, 1996-05, Vol.1 (2), p.117-128

1996

Link zum Volltext

Verfügbarkeit prüfen

Cerebrospinal fluid chromogranin A is unchanged in Alzheimer dementia

Neurobiology of aging, 1993-05, Vol.14 (3), p.267-269

1993

Link zum Volltext

Verfügbarkeit prüfen

Factitious pheochromocytoma: Novel mimickry by valsalva maneuver and clues to diagnosis

American journal of hypertension, 1995-06, Vol.8 (6), p.651-655

1995

Link zum Volltext

Verfügbarkeit prüfen

The regulation and role of catecholamines in hypertension and pheochromocytoma

Current opinion in endocrinology & diabetes, 1994-01, Vol.1 (1), p.135-142

1994

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(28)
Berichte
(1)

Sprache

Englisch
(29)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(18)
Life Sciences & Biomedicine
(16)
Science & Technology
(16)
Biological And Medical Sciences
(14)
Female
(14)
Male
(14)
Medical Sciences
(14)
Adult
(11)
Cardiovascular System & Cardiology
(11)
Middle Aged
(11)
Hypertension - Genetics
(10)
Peripheral Vascular Disease
(10)
Arterial Hypertension. Arterial Hypotension
(9)
Blood And Lymphatic Vessels
(9)
Cardiology. Vascular System
(9)
Chromogranin A
(9)
Clinical Manifestations. Epidemiology. Investigative Techniques. Etiology
(9)
Hypertension
(9)
Genetics
(8)
Hypertension - Blood
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Early decline in the catecholamine release-inhibitory peptide catestatin in humans at genetic risk of hypertension

Plasma Hydrogen Peroxide Production in Human Essential Hypertension: Role of Heredity, Gender, and Ethnicity

Development and Validation of a Noninvasive Method to Determine Arterial Pressure and Vascular Compliance

β2-Adrenergic receptor polymorphisms at codon 16, cardiovascular phenotypes and essential hypertension in whites and African Americans

Diminished renal kallikrein responses to mineralocorticoid stimulation in African Americans: determinants of an intermediate phenotype for hypertension

Circulating amylin in human essential hypertension: heritability and early increase in individuals at genetic risk

Chromogranin A in Human Hypertension: Influence of Heredity

Early Alteration in Glomerular Reserve in Humans at Genetic Risk of Essential Hypertension: Mechanisms and Consequences

The catecholamine release-inhibitory "catestatin" region of chromogranin a: early decline in humans at genetic risk of hypertension

Divergent Effects of Dihydropyridine and Phenylalkylamine Calcium Channel Antagonist Classes on Autonomic Function in Human Hypertension

Arterial Compliance by Cuff Sphygmomanometer: Application to Hypertension and Early Changes in Subjects at Genetic Risk

Human sympathetic activation by α2‐adrenergic blockade with yohimbine: Bimodal, epistatic influence of cytochrome P450–mediated drug metabolism

Expression of altered α2-adrenergic phenotypic traits in normotensive humans at genetic risk of hereditary (essential) hypertension

Does lipophilicity of angiotensin converting enzyme inhibitors selectively influence autonomic neural function in human hypertension?

Variability in phenylephrine response and essential hypertension: a search for human alpha(1B)-adrenergic receptor polymorphisms

The Catecholamine Release-Inhibitory "Catestatin" Region of Chromogranin A

Human sympathetic activation by alpha2-adrenergic blockade with yohimbine: Bimodal, epistatic influence of cytochrome P450-mediated drug metabolism

Early alteration in glomerular reserve in humans at genetic risk of essential hypertension: Mechanisms and conquences

Racial differences in renal kallikrein excretion: Effect of the ovulatory cycle

β 2-adrenergic receptor polymorphisms at codon 16, cardiovascular phenotypes and essential hypertension in whites and African Americans

2-Adrenergic receptor polymorphisms at codon 16, cardiovascular phenotypes and essential hypertension in whites and African Americans

Hereditary intermediate phenotypes in African American hypertension

Cerebrospinal fluid chromogranin A is unchanged in Alzheimer dementia

Factitious pheochromocytoma: Novel mimickry by valsalva maneuver and clues to diagnosis

The regulation and role of catecholamines in hypertension and pheochromocytoma

Suchergebnisse filtern